SCHEMBL1034265

SCHEMBL1034265

CCOC(=O)C(C)Oc1ccc(C(=O)CCc2sc3ccc(C(F)(F)F)cc3c2C)cc1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.43
KMT2A Q03164 2/20 0.39
PPARD Q03181 1/20 0.36
LMNA P02545 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX2 P34913 2/20 0.35
MAPT P10636 3/20 0.34
TP53 P04637 2/20 0.34
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH2 P05091 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034043 0.93 IDH1 (0.41) IDH1KMT2APPARDLMNAL3MBTL1
SCHEMBL1035195 0.91 PPARA (0.40) PPARDSMN1; SMN2
SCHEMBL1032853 0.83 PPARA (0.40) PPARDSMN1; SMN2
SCHEMBL1082175 0.81 PPARA (0.37) PPARD
SCHEMBL4655072 0.79 LMNA (0.38) KMT2ALMNAEPHX2MAPTTP53
SCHEMBL1034264 0.77 ESR1 (0.43) IDH1PPARD
SCHEMBL1032891 0.77 BCL2L1 (0.37) KMT2AMAPTMEN1
SCHEMBL1030579 0.76 FBP1 (0.38) PPARDLMNATP53
SCHEMBL1082173 0.76 PPARD (0.46) PPARDSMN1; SMN2
SCHEMBL27829362 0.76 KCNK3 (0.41) KMT2ALMNAMAPTTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
CN-102083810-B Activator of peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO.,LTD. (JP) 2014-10-29 CN disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
CN-102083810-A Activator of peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO 2011-06-01 CN disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD IDH1 471/4885KMT2A 2414/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.